المؤلفون: Puente J; Medical Oncology Department, Instituto de Investigación Biomédica, Hospital Clínico Universitario San Carlos, Madrid, Spain., Laínez N; Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain., Dueñas M; Molecular Oncology Unit CIEMAT and Instituto Investigación Biomédica, Hospital Universitario 12 de Octubre, Madrid, Spain.; CIBERONC, Spain., Méndez-Vidal MJ; Medical Oncology Department, Hospital Universitario Reina Sofía, Córdoba, Spain., Esteban E; Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Castellano D; CIBERONC, Spain.; Medical Oncology Department, and Instituto Investigación Biomédica, Hospital Universitario 12 de Octubre, Madrid, Spain., Martinez-Fernández M; Molecular Oncology Unit CIEMAT and Instituto Investigación Biomédica, Hospital Universitario 12 de Octubre, Madrid, Spain.; CIBERONC, Spain., Basterretxea L; Medical Oncology Department, Hospital Donostia, Donostia, Spain., Juan-Fita MJ; Medical Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain., Antón L; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain., León L; Promoción e Planificación da Investigación Sanitaria, Axencia de Coñecemento en Saúde, Santiago de Compostela, Spain., Lambea J; Medical Oncology Department, Hospital Clínico de Zaragoza, Zaragoza, Spain., Pérez-Valderrama B; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Vázquez S; Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain., Suarez C; Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d' Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Del Muro XG; Medical Oncology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, L'Hospitalet, Barcelona, Spain., Gallardo E; Medical Oncology Department, Hospital Universitari Parc Taulí, Sabadell, Spain., Maroto JP; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Samaniego ML; Statistical Department, Trial Form Support TFS people, Madrid, Spain., Suárez-Paniagua B; Oncology Medical Department, Trial Form Support, Madrid, Spain., Sanz J; Pathology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain., Paramio JM; Molecular Oncology Unit CIEMAT and Instituto Investigación Biomédica, Hospital Universitario 12 de Octubre, Madrid, Spain.; CIBERONC, Spain.

مؤلفون مشاركون: SOGUG (Spanish Oncology Genitourinary Group)

المصدر: Oncotarget [Oncotarget] 2017 May 02; Vol. 8 (18), pp. 30410-30421.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor*, Carcinoma, Renal Cell/*metabolism , Carcinoma, Renal Cell/*mortality, Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Carcinoma, Renal Cell/drug therapy ; Carcinoma, Renal Cell/pathology ; Drug Resistance, Neoplasm ; Female ; Gene Expression Profiling ; Humans ; Indoles/administration & dosage ; Indoles/adverse effects ; Indoles/therapeutic use ; Kaplan-Meier Estimate ; Male ; MicroRNAs/genetics ; Molecular Targeted Therapy ; Neoplasm Staging ; Prognosis ; Pyrroles/administration & dosage ; Pyrroles/adverse effects ; Pyrroles/therapeutic use ; ROC Curve ; Retrospective Studies ; Signal Transduction ; Sunitinib

SCR Disease Name: Clear-cell metastatic renal cell carcinoma

المؤلفون: González Del Alba A; Medical Oncology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain., Arranz JÁ; Medical Oncology Department, Unit of Urological and Gynecological Tumors, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Puente J; Medical Oncology Department, Hospital Universitario San Carlos, Madrid, Spain., Méndez-Vidal MJ; Oncology Department, Maimonides Institute of Medical Research (IMIBIC), Hospital Universitario Reina Sofía, Córdoba, Spain., Gallardo E; Oncology Department, Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain., Grande E; Medical Oncology Department, GI, Endocrine and Translational Research Unit, Early Drug Development Unit-IRYCIS, Hospital Universitario Ramón y Cajal, Madrid, Spain., Pérez-Valderrama B; Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain., González-Billalabeitia E; Medical Oncology and Hematology Department, Hospital G.U. Morales Meseguer, Murcia, Spain., Lázaro-Quintela M; Medical Oncology Department, Complexo Hospitalario Universitario de Vigo, Vigo, Spain., Pinto Á; Medical Oncology Department, Hospital Universitario La Paz, Instituto de Investigación Sanitaria Hospital La Paz (IdiPAZ), Madrid, Spain., Lainez N; Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain., Piulats JM; Medical Oncology Department, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain., Esteban E; Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Maroto Rey JP; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., García JA; Hematology/Oncology and Urology Departments, Cleveland Clinic, Cleveland, OH, United States., Suárez C; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: csuarez@vhio.net.

المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2017 May; Vol. 113, pp. 171-190. Date of Electronic Publication: 2017 Mar 14.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Urogenital Neoplasms/*drug therapy, Antineoplastic Agents/pharmacology ; Humans ; Male ; Urogenital Neoplasms/metabolism ; Urogenital Neoplasms/pathology

المؤلفون: Cebrián A; Fundación Jiménez Díaz University Hospital, Madrid, Spain., Gómez Del Pulgar T; Fundación Jiménez Díaz University Hospital, Madrid, Spain., Méndez-Vidal MJ; Reina Sofía University Hospital, Córdoba, Spain., Gonzálvez ML; Virgen de la Arrixaca University Hospital, Murcia, Spain., Lainez N; Complejo Hospitalario de Navarra, Pamplona, Spain., Castellano D; 12 de Octubre University Hospital, Madrid, Spain., García-Carbonero I; Virgen de la Salud University Hospital, Toledo, Spain., Esteban E; Central University Hospital of Asturias, Oviedo, Spain., Sáez MI; Virgen de la Victoria University Hospital, Málaga, Spain., Villatoro R; Hospital Costa del Sol, Marbella, Spain., Suárez C; Vall d'Hebron University Hospital, Barcelona, Spain., Carrato A; Ramon y Cajal University Hospital, Madrid, Spain., Munárriz-Ferrándiz J; Hospital Provincial de Castellón, Castellón, Spain., Basterrechea L; Hospital de Donostia, San Sebastian, Spain., García-Alonso M; Insular de Gran Canaria University Hospital, Islas Canarias, Spain., González-Larriba JL; Clinico San Carlos University Hospital, Madrid, Spain., Perez-Valderrama B; Virgen del Rocío University Hospital, Sevilla, Spain., Cruz-Jurado J; Canarias University Hospital, Santa Cruz de Tenerife, Islas Canarias, Spain., González Del Alba A; Son Espases University Hospital, Palma de Mallorca, Spain., Moreno F; Fuenlabrada University Hospital, Fuenlabrada, Spain., Reynés G; La Fe University Hospital, Valencia, Spain., Rodríguez-Remírez M; Fundación Jiménez Díaz University Hospital, Madrid, Spain., Boni V; Center for Applied Medical Research, Pamplona, Spain., Mahillo-Fernández I; Fundación Jiménez Díaz University Hospital, Madrid, Spain., Martin Y; Trial Form Support, Madrid, Spain., Viqueira A; Pfizer Oncology, Madrid, Spain., García-Foncillas J; Fundación Jiménez Díaz University Hospital, Madrid, Spain.

المصدر: Scientific reports [Sci Rep] 2017 Jan 24; Vol. 7, pp. 41371. Date of Electronic Publication: 2017 Jan 24.

نوع المنشور: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*genetics , Carcinoma, Renal Cell/*drug therapy , Carcinoma, Renal Cell/*genetics , Cyclooxygenase 2/*genetics , Indoles/*therapeutic use , Kidney Neoplasms/*drug therapy , Kidney Neoplasms/*genetics , Polymorphism, Single Nucleotide/*genetics , Pyrroles/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Disease-Free Survival ; Female ; Gene Frequency/genetics ; Genetic Association Studies ; Humans ; Indoles/pharmacology ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Models, Genetic ; Multivariate Analysis ; Pyrroles/pharmacology ; Sunitinib ; Treatment Outcome

المؤلفون: Pérez-Valderrama B; Department of Medical Oncology, Virgen del Rocío University Hospitals, Sevilla bperezv@gmail.com., Arranz Arija JA; Department of Medical Oncology, Gregorio Marañón General University Hospital, Madrid., Rodríguez Sánchez A; Department of Medical Oncology, University Hospital of León, Leon., Pinto Marín A; Department of Medical Oncology, La Paz University Hospital, Madrid., Borrega García P; Department of Medical Oncology, San Pedro de Alcántara Hospital, Cáceres., Castellano Gaunas DE; Department of Medical Oncology, 12 de Octubre University Hospital, Madrid., Rubio Romero G; Department of Medical Oncology, Fundación Jiménez Díaz University Hospital, Madrid., Maximiano Alonso C; Department of Medical Oncology, Puerta de Hierro University Hospital, Majadahonda (Madrid)., Villa Guzmán JC; Department of Medical Oncology, General University Hospital of Ciudad Real, Ciudad Real., Puertas Álvarez JL; Department of Medical Oncology, Rio Hortega University Hospital, Valladolid., Chirivella González I; Department of Medical Oncology, University Hospital of Valencia, Valencia., Méndez Vidal MJ; Department of Medical Oncology, Reina Sofía University Hospital, Córdoba., Juan Fita MJ; Department of Medical Oncology, Valencian Institute of Oncology, Valencia., León-Mateos L; Department of Medical Oncology, Santiago University Hospital Complex, Santiago de Compostela., Lázaro Quintela M; Department of Medical Oncology, University Hospital Complex of Vigo, Vigo., García Domínguez R; Department of Medical Oncology, Clinic University Hospital of Salamanca, Salamanca., Jurado García JM; Department of Medical Oncology, San Cecilio University Hospital, Granada., Vélez de Mendizábal E; Department of Medical Oncology, San Pedro Hospital, Logroño., Lambea Sorrosal JJ; Department of Medical Oncology, Lozano Blesa University Hospital, Zaragoza., García Carbonero I; Department of Medical Oncology, Virgen de la Salud Hospital, Toledo., González del Alba A; Department of Medical Oncology, Son Espases University Hospital, Palma de Mallorca., Suárez Rodríguez C; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona., Jiménez Gallego P; Department of Medical Oncology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas de Gran Canaria., Meana García JA; Department of Medical Oncology, University Hospital of Alicante, Alicante., García Marrero RD; Department of Medical Oncology, University Hospital of Canarias, San Cristóbal de La Laguna (Santa Cruz de Tenerife)., Gajate Borau P; Department of Medical Oncology, Quirón University Hospital, Madrid., Santander Lobera C; Department of Medical Oncology, Miguel Servet University Hospital, Zaragoza., Molins Palau C; Department of Medical Oncology, Doctor Peset University Hospital, Valencia., López Brea M; Department of Medical Oncology, Marqués de Valdecilla University Hospital, Santander., Fernández Parra EM; Department of Medical Oncology, Nuestra Señora de Valme University Hospital, Sevilla., Reig Torras O; Department of Medical Oncology, Clinic University Hospital of Barcelona, Barcelona., Basterretxea Badiola L; Department of Medical Oncology, Donostia University Hospital, San Sebastián., Vázquez Estévez S; Department of Medical Oncology, Lucus Augusti University Hospital, Lugo., González Larriba JL; Department of Medical Oncology, San Carlos University Hospital, Madrid, Spain.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2016 Apr; Vol. 27 (4), pp. 706-11. Date of Electronic Publication: 2015 Dec 09.

نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Molecular Targeted Therapy* , Prognosis*, Carcinoma, Renal Cell/*drug therapy , Pyrimidines/*administration & dosage , Sulfonamides/*administration & dosage, Adult ; Aged ; Carcinoma, Renal Cell/pathology ; Databases, Factual ; Disease-Free Survival ; Female ; Humans ; Indazoles ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Pyrimidines/adverse effects ; Retrospective Studies ; Risk Factors ; Spain ; Sulfonamides/adverse effects

المؤلفون: Lainez N; Department of oncology, Complejo Hospitalario de Navarra, Servicio Oncología Médica. Pabellón B 2ª planta. Hospital de día, C/ Irunlarrea, 3, 31008, Pamplona, Navarra, Spain. nuria.lainez.milagro@cfnavarra.es., García-Donas J; Department of oncology, Hospital Sanchinarro, C/ Oña, 10, 28050, Madrid, Spain. jgarciadonas@gmail.com., Esteban E; Department of oncology, Hospital Universitario Central de Asturias, Julián Clavería s/n, 33006, Oviedo, Spain. eestebang@seom.org., Puente J; Department of oncology, Hospital Clínico de Madrid, C/ Doctor Martín Lagos s/n, 28040, Madrid, Spain. jpuente.hcsc@salud.madrid.org., Sáez MI; Department of oncology, Hospital Universitario Clínico Virgen de la Victoria, Campus Universitario de Teatinos, s/n, 29010, Málaga, Spain. msaez.med@gmail.com., Gallardo E; Department of oncology, Parc Taulí Sabadell Hospital Universitari, Parc Taulí 1, 08208, Sabadell, Spain. egallardo@tauli.cat., Pinto-Marín Á; Department of oncology, Hospital Universitario La Paz, P de la Castellana 261, 28046, Madrid, Spain. alvaropintomarin@gmail.com., Vázquez-Estévez S; Department of oncology, Hospital Universitario Lucus Augusti, Lugar San Cibrao, S/N, 27003, Lugo, Spain. Sergio.Vazquez.Estevez@sergas.es., León L; Department of oncology, Hospital Santiago de Compostela, Travesía da Choupana, s/n, 15706, Santiago de Compostela, Spain. Luis.Leon.Mateos@sergas.es., García-Carbonero I; Department of oncology, Hospital Virgen de la Salud, Adva. De Barber, 30, 45004, Toledo, Spain. igcarbonero@yahoo.es., Suárez-Rodríguez C; Department of oncology, Hospital Vall d'Hebron, Ps Vall d'Hebron, 119-129, 8035, Barcelona, Spain. crisuarez08@gmail.com., Molins C; Department of oncology, Hospital Universitario Dr. Peset, Avda. Gaspar Aguilar 90, 46017, Valencia, Spain. molins_car@gva.es., Climent-Duran MA; Department of oncology, Instituto Valenciano de Oncología, Gregorio Gea, 31-1° Planta, 46009, Valencia, Spain. macliment@fivo.org., Lázaro-Quintela M; Department of oncology, Complexo Hospitalario Universitario de Vigo, Pizarro 22, 36204, Vigo, Spain. martin.lazaro.quintela@sergas.es., González Del Alba A; Department of oncology, Hospital Universitario Son Espases, Ctra Valldemossa, 79, 07010, Palma de Mallorca, Spain. aranzazu.gonzalezdelalba@ssib.es., Méndez-Vidal MJ; Department of oncology, Hospital Universitario Reina Sofía, Avda. Menéndez Pidal, s/n, 14004, Córdoba, Spain. mjosemv@yahoo.es., Chirivella I; Department of oncology, Hospital Clínico de Valencia, Avda Blasco Ibáñez, 17, 46010, Valencia, Spain. chirivella_isa@gva.es., Afonso FJ; Department of oncology, Complejo Hospitalario Arquitecto Marcide, Rúa da residencia s/n. San pedro de Leixa, 15405, Ferrol, Spain. Francisco.Javier.Afonso.Afonso@sergas.es., López-Brea M; Department of oncology, Hospital Marqués de Valdecilla, Avda. Valdecila s/n, 39008, Santander, Spain. marta.lopezbrea@gmail.com., Sala-González N; Department of oncology, ICO de Girona, Francia s/n, 17007, Gerona, Spain. nsgonzalez@iconcologia.net., Domenech M; Department of oncology, Hospital de Althaia Xarxa Asistencial Manresa, Dr. Joan Soler, 1-3, 08243, Barcelona, Spain. mdomenech@althaia.cat., Basterretxea L; Department of oncology, Hospital de Donostia, P° Dr. Beguiristain 109, 20014, San Sebastian, Spain. laura.basterrechea@osakidetza.net., Santander-Lobera C; Department of oncology, Hospital Miguel Servet, Avda Gómez Laguna 25, 50009, Zaragoza, Spain. csantlob@yahoo.es., Gil-Arnáiz I; Department of oncology, Hospital Reina Sofía, Carretera Tarazona, KM 3, 31500, Tudela, Spain. irenega6@hotmail.com., Fernández O; Department of oncology, Complejo Hospitalario Ourense. Hospital Santa María Nai, Ramón Puga, 52-54, 32005, Orense, Spain. ovidiofernandezcalvo@yahoo.es., Caballero-Díaz C; Department of oncology, Hospital General Universitario de Valencia, Avda Tres Cruces, s/n, 46014, Valencia, Spain. caballero_cri@gva.es., Mellado B; Department of oncology, IDIBAPS, Hospital Clinic i Provincial de Barcelona, Villarroel, 170, 08036, Barcelona, Spain. BMELLADO@clinic.ub.es., Marrupe D; Department of oncology, Hospital Universitario de Móstoles, Río Júcar s/n, 28935, Móstoles, Madrid, Spain. david.marrupe@gmail.com., García-Sánchez J; Department of oncology, Hospital Arnau de Vilanova, C/ San Clemente n 12, 46015, Valencia, Spain. joseche812@hotmail.com., Sánchez-Escribano R; Department of oncology, Hospital Universitario de Burgos, Avenida Cid Campeador, 96, 09005, Burgos, Spain. rsescribano@seom.org., Fernández Parra E; Department of oncology, H.U. Hospital de Valme, Ctra. de Cádiz Km. 548.9, 41014, Sevilla, Spain. evamfparra@yahoo.es., Villa Guzmán JC; Department of oncology, Hospital de Ciudad Real, Obispo Rafael Torija, 13005, Ciudad Real, Spain. jvillaguzman1@yahoo.es., Martínez-Ortega E; Department of oncology, Hospital Ciudad de Jaén, Avenida Ejercito Español 10, 23007, Jaén, Spain. esthermartinezz@yahoo.es., Belén González M; Department of oncology, Hospital Son Llatzer, Ctra. Manacor, km.4, Sont Frriol, 07198, Palma de Mallorca, Spain. mbgonzal@hsll.es., Morán M; Pfizer Madrid, Avda. de Europa, 20B, 28108, Alcobendas, Madrid, Spain. marina.moran@pfizer.com., Suarez-Paniagua B; Trial Form Support, Avda. de Europa, 20B, 28108, Alcobendas, Madrid, Spain. Beatriz.suarez@tfscro.com., Lecumberri MJ; Department of oncology, Complejo Hospitalario de Navarra, Servicio Oncología Médica. Pabellón B 2ª planta. Hospital de día, C/ Irunlarrea, 3, 31008, Pamplona, Navarra, Spain. mj.lecumberri.biurrun@navarra.es., Castellano D; Department of oncology, Hospital 12 de Octubre, Av. de Córdoba s/n, 28041, Madrid, Spain. cdanicas@hotmail.com.

المصدر: BMC cancer [BMC Cancer] 2016 Feb 22; Vol. 16, pp. 135. Date of Electronic Publication: 2016 Feb 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*adverse effects , Carcinoma, Renal Cell/*drug therapy , Kidney Neoplasms/*drug therapy, Aged ; Antineoplastic Agents/therapeutic use ; Female ; Guideline Adherence/statistics & numerical data ; Humans ; Male ; Middle Aged ; Molecular Targeted Therapy/adverse effects ; Neoplasm Metastasis ; Practice Guidelines as Topic ; Spain

المؤلفون: Climent MÁ; Instituto Valenciano de Oncología (IVO), Valencia, Spain. Electronic address: macliment@fivo.org., León-Mateos L; Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain., González Del Alba A; Hospital Universitario Son Espases, Palma de Mallorca, Spain., Pérez-Valderrama B; Hospital Universitario Virgen del Rocío, Sevilla, Spain., Méndez-Vidal MJ; Hospital Universitario Reina Sofía, Córdoba, Spain., Mellado B; Hospital Clínic, IDIBAPS, Barcelona, Spain., Arranz JÁ; Hospital General Universitario Gregorio Marañón, Madrid, Spain., Sánchez-Hernández A; Consorcio Hospitalario Provincial de Castellón, Castellón, Spain., Cassinello J; Hospital Universitario de Guadalajara, Guadalajara, Spain., Olmos D; Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Carles J; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain.

المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2015 Nov; Vol. 96 (2), pp. 308-18. Date of Electronic Publication: 2015 Jun 08.

نوع المنشور: Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant/*therapy, Antineoplastic Agents/therapeutic use ; Humans ; Male

المؤلفون: Suárez C; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain., Puente J; Medical Oncology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain., Gallardo E; Medical Oncology Department, Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain., Méndez-Vidal MJ; Medical Oncology Department, Instituto Maimónides de Investigación Biomédica (IMIBIC), Hospital Universitario Reina Sofía, Córdoba, Spain., Climent MA; Medical Oncology Department, Fundación Instituto Valenciano de Oncología, Valencia, Spain., León L; Medical Oncology Department, Hospital Clínico, Santiago de Compostela, A Coruña, Spain., Olmos D; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; CNIO-IBIMA Genitourinary Cancer Research Unit, Hospitales Universitarios Virgen de la Victoria & Regional de Málaga, Madrid, Spain.; Centro Integral Oncológico Clara Campal, Madrid, Spain., García del Muro X; Institut Català d'Oncologia L'Hospitalet, Barcelona, Spain., González-Billalabeitia E; Medical Oncology and Hematology Department, Hospital G. U. Morales Meseguer, Murcia, Spain., Grande E; Medical Oncology Department, GI, Endocrine and Translational Research Unit, Early Drug Development Unit-IRYCIS, Ramon y Cajal University Hospital, Madrid, Spain., Bellmunt J; Bladder Cancer Center, Dana-Farber Cancer Institute, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA., Mellado B; Medical Oncology Department, Hospital Clinic, Barcelona, Spain., Maroto P; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., González del Alba A; Medical Oncology Department, Hospital Universitario Son Espases, Carretera de Valldemosa 79, 07010, Palma de Mallorca, Spain. aranzazu.gonzalezdelalba@ssib.es.

المصدر: Cancer metastasis reviews [Cancer Metastasis Rev] 2015 Sep; Vol. 34 (3), pp. 443-64.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8605731 Publication Model: Print Cited Medium: Internet ISSN: 1573-7233 (Electronic) Linking ISSN: 01677659 NLM ISO Abbreviation: Cancer Metastasis Rev Subsets: MEDLINE

مواضيع طبية MeSH: Urogenital Neoplasms/*therapy, Humans

المؤلفون: Espinosa J; Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., González-Larriba JL; Hospital Clínico San Carlos, Madrid, Spain., Maroto P; Hospital Sant Pau, Barcelona, Spain., Méndez-Vidal MJ; Hospital Reina Sofía, Córdoba, Spain., Díaz-Cerezo S; GSK España, Tres Cantos, Spain.

المصدر: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2014 Nov; Vol. 17 (7), pp. A632-3. Date of Electronic Publication: 2014 Oct 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: PubMed not MEDLINE

المؤلفون: Castellano D; University Hospital 12 de Octubre, Medical Oncology Department, Urooncology Unit (I+12 Research Institute) , Avda. de Cordoba, s/n, 28041 Madrid , Spain., Antón Aparicio LM, Esteban E, Sánchez-Hernández A, Germà JR, Batista N, Maroto P, Pérez-Valderrama B, Luque R, Méndez-Vidal MJ

مؤلفون مشاركون: cabazitaxel EAP study

المصدر: Expert opinion on drug safety [Expert Opin Drug Saf] 2014 Sep; Vol. 13 (9), pp. 1165-73. Date of Electronic Publication: 2014 Jul 07.

نوع المنشور: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-764X (Electronic) Linking ISSN: 14740338 NLM ISO Abbreviation: Expert Opin Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*adverse effects , Prostatic Neoplasms, Castration-Resistant/*drug therapy , Taxoids/*adverse effects, Aged ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Docetaxel ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Prednisolone/administration & dosage ; Prostatic Neoplasms, Castration-Resistant/pathology ; Spain ; Taxoids/administration & dosage ; Taxoids/therapeutic use

المؤلفون: León L; Medical Oncology Department, Complejo Hospitalario Universitario de Santiago, A Coruña, Spain, luis.leon.mateos@sergas.es., García-Figueiras R, Suárez C, Arjonilla A, Puente J, Vargas B, Méndez Vidal MJ, Sebastiá C

المصدر: Targeted oncology [Target Oncol] 2014 Mar; Vol. 9 (1), pp. 9-24. Date of Electronic Publication: 2013 Dec 12.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Practice Guidelines as Topic*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carcinoma, Renal Cell/*diagnosis , Carcinoma, Renal Cell/*drug therapy , Kidney Neoplasms/*diagnosis , Kidney Neoplasms/*drug therapy, Biomarkers, Pharmacological/analysis ; Carcinoma, Renal Cell/pathology ; Clinical Trials as Topic ; Diagnostic Imaging/methods ; Humans ; Kidney Neoplasms/pathology ; Molecular Targeted Therapy ; Neoplasm Metastasis ; Prognosis ; Treatment Outcome